BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26524350)

  • 1. Adequacy in voided urine cytology specimens: The role of volume and a repeat void upon predictive values for high-grade urothelial carcinoma.
    VandenBussche CJ; Rosenthal DL; Olson MT
    Cancer Cytopathol; 2016 Mar; 124(3):174-80. PubMed ID: 26524350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy criteria for voided urine cytology using cytospin preparations.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2019 Feb; 127(2):116-119. PubMed ID: 30561909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of appropriate urine volume cutoff values for voided urine specimens to assess adequacy.
    Xing J; Qi Y; Monaco SE; Pantanowitz L
    J Am Soc Cytopathol; 2019; 8(2):89-94. PubMed ID: 31287425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy of voided urine specimens prepared by ThinPrep and evaluated using The Paris System for Reporting Urinary Cytology.
    Rezaee N; Tabatabai ZL; Olson MT
    J Am Soc Cytopathol; 2017; 6(4):155-161. PubMed ID: 31043268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic significance of 'atypia' in instrumented versus voided urine specimens.
    Kapur U; Venkataraman G; Wojcik EM
    Cancer; 2008 Aug; 114(4):270-4. PubMed ID: 18548527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of atypical urine cytology progression to malignancy.
    Muus Ubago J; Mehta V; Wojcik EM; Barkan GA
    Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
    Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
    Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical urothelial tissue fragments in noninstrumented voided urine specimens are associated with low but significantly higher rates of urothelial neoplasia than benign-appearing urothelial tissue fragments.
    Onur I; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2015 Mar; 123(3):186-92. PubMed ID: 25586692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
    VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H
    Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adequacy of urine cytology specimens: an assessment of collection techniques.
    Hundley AF; Maygarden S; Wu JM; Visco AG; Connolly A
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Sep; 18(9):997-1001. PubMed ID: 17205220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
    Zhang ML; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2016 Aug; 124(8):552-64. PubMed ID: 27019161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of urinary cytology in the evaluation of bladder neoplasms.
    Murphy WM
    Hum Pathol; 1990 Sep; 21(9):886-96. PubMed ID: 2203672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma.
    Pierconti F; Martini M; Straccia P; Fiorentino V; Musarra T; Larocca LM; Lopez-Beltran A
    APMIS; 2018 Sep; 126(9):705-709. PubMed ID: 30160022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When words matter: A "suspicious" urinary tract cytology diagnosis improves patient follow-up among nonurologists.
    Fite JJ; Rosenthal DL; VandenBussche CJ
    Cancer Cytopathol; 2018 Apr; 126(4):282-288. PubMed ID: 29360190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer.
    Yafi FA; Brimo F; Auger M; Aprikian A; Tanguay S; Kassouf W
    Urol Oncol; 2014 Jan; 32(1):27.e1-6. PubMed ID: 23410943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of an artificial intelligence algorithm for reporting urine cytopathology.
    Sanghvi AB; Allen EZ; Callenberg KM; Pantanowitz L
    Cancer Cytopathol; 2019 Oct; 127(10):658-666. PubMed ID: 31412169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.